Jack Nathan Health Reports Q3 Fiscal 2025 Results
Written by Emily J. Thompson, Senior Investment Analyst
Source: Business Insider
Updated: Dec 30 2024
0mins
Source: Business Insider
Company Performance: Jack Nathan Medical (TSE:JNH) reported a 16% year-to-date revenue growth in Q3 fiscal 2025, mainly due to its expanding operations in Mexico after selling its Canadian operations.
Future Focus: The company is concentrating on growing its Mexican clinics and exploring opportunities in the MedSpa sector.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
